Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,283 | 4,508 | 7,821 | 8,317 | 8,335 |
| Receivables | 16,099 | 16,705 | 21,834 | 17,766 | 20,704 |
| Inventories | 24,716 | 26,439 | 27,587 | 22,262 | 22,061 |
| Other current assets | 3,940 | 3,472 | 4,341 | 3,355 | 2,472 |
| TOTAL | $49,038 | $51,124 | $61,583 | $51,700 | $53,572 |
| Non-Current Assets | |||||
| PPE Net | 3,981 | 3,366 | 3,415 | 3,960 | 4,776 |
| Intangibles | 73,101 | 77,274 | 85,074 | 91,741 | 95,786 |
| Other Non-Current Assets | 11,246 | 13,596 | 12,272 | 8,853 | 10,736 |
| TOTAL | $88,328 | $94,236 | $100,761 | $104,554 | $111,298 |
| Total Assets | $137,366 | $145,360 | $162,344 | $156,254 | $164,870 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,859 | 3,811 | 3,235 | 1,721 | 6,900 |
| Accounts payable and accrued liabilities | 5,554 | 6,447 | 4,911 | 5,972 | 5,339 |
| Other current liabilities | 13,713 | 10,856 | 10,762 | 7,478 | 6,700 |
| TOTAL | $26,542 | $23,249 | $25,316 | $21,053 | $25,312 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,704 | 43,013 | 45,095 | 46,286 | 46,917 |
| Deferred Revenues | N/A | N/A | 4,266 | 3,771 | 3,949 |
| Other Non-Current Liabilities | 6,270 | 6,288 | 6,974 | 10,335 | 8,973 |
| TOTAL | $37,750 | $49,891 | $53,627 | $58,520 | $57,864 |
| Total Liabilities | $64,292 | $73,140 | $78,943 | $79,573 | $83,176 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,399 | 42,190 | 41,230 | 39,826 | 38,348 |
| Common Shares | 434 | 454 | 452 | 444 | 438 |
| Retained earnings | -145,605 | -142,190 | -132,674 | -132,386 | -124,576 |
| Other shareholders' equity | -14,190 | -15,052 | -10,027 | -12,734 | -12,357 |
| TOTAL | $73,074 | $72,220 | $83,401 | $76,681 | $81,694 |
| Total Liabilities And Equity | $137,366 | $145,360 | $162,344 | $156,254 | $164,870 |